SCHEMBL4328141

SCHEMBL4328141

Cn1ccc(-c2cccc(OC(N)=O)c2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.53
MEN1 O00255 2/20 0.53
MKNK1 Q9BUB5 1/20 0.45
MKNK2 Q9HBH9 1/20 0.45
ADORA2A P29274 2/20 0.43
ADORA1 P30542 2/20 0.43
PARP1 P09874 1/20 0.42
KEAP1 Q14145 1/20 0.41
SCN9A Q15858 1/20 0.41
IRAK4 Q9NWZ3 1/20 0.41
SCN4A P35499 1/20 0.41
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
TP53 P04637 1/20 0.40
KLK3 P07288 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15885087 0.79 KMT2A (0.56) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL4452243 0.78 KMT2A (0.47) KMT2AMEN1SCN9ASCN4ANPC1
SCHEMBL2629325 0.77 KMT2A (0.50) KMT2AMEN1MKNK1MKNK2KEAP1
SCHEMBL28790901 0.75 MAPK1 (0.54) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL24378643 0.75 KMT2A (0.51) KMT2AMEN1SMN1; SMN2TP53KDM4E
SCHEMBL939191 0.74 JMJD6 (0.65) KMT2AMKNK1MKNK2KEAP1NPC1
SCHEMBL23213539 0.74 CYP1A2 (0.55) KMT2AMEN1NPC1RAB9ASMN1; SMN2
SCHEMBL10695393 0.74 POLB (0.54) KMT2ASMN1; SMN2KDM4EALDH1A1MAPT
SCHEMBL24378642 0.74 KCNH2 (0.58) KMT2AIRAK4SCN4A
SCHEMBL16963931 0.74 KMT2A (0.50) KMT2AKEAP1SCN4AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109153636-B Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors 朱比连特埃皮科尔有限责任公司 2021-10-22 CN disclosed
WO-2009090548-A2 3-AZABICYCLO [3.1.0] HEXANE DERIVATIVES AS VANILLOID RECEPTOR LIGANDS GLENMARK PHARMACEUTICALS, S.A. (US) 2009-07-23 WO disclosed